| __timestamp | Regeneron Pharmaceuticals, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 205018000 | 18516000 |
| Thursday, January 1, 2015 | 392709000 | 34140000 |
| Friday, January 1, 2016 | 299694000 | 51872000 |
| Sunday, January 1, 2017 | 397061000 | 71772000 |
| Monday, January 1, 2018 | 434100000 | 97501000 |
| Tuesday, January 1, 2019 | 782200000 | 118590000 |
| Wednesday, January 1, 2020 | 1119900000 | 169802000 |
| Friday, January 1, 2021 | 2437500000 | 7491000 |
| Saturday, January 1, 2022 | 1560400000 | 8799000 |
| Sunday, January 1, 2023 | 1815800000 | 253598000 |
| Monday, January 1, 2024 | 1970500000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, cost efficiency is a critical factor for success. Regeneron Pharmaceuticals, Inc. and Xencor, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Regeneron, a leader in the industry, has seen its cost of revenue grow by approximately 785% over this period, peaking in 2021. In contrast, Xencor's cost of revenue, while significantly lower, has experienced a more modest increase of around 1,270%, with a notable spike in 2023. This divergence highlights Regeneron's expansive growth strategy, while Xencor's leaner operations suggest a focus on efficiency. The data underscores the importance of strategic financial management in sustaining competitive advantage in the biotech sector. As the industry evolves, these insights provide a window into the operational strategies of two influential players.
Analyzing Cost of Revenue: Johnson & Johnson and Xencor, Inc.
Cost Insights: Breaking Down AstraZeneca PLC and Xencor, Inc.'s Expenses
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Geron Corporation
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Evotec SE's Expenses
Catalent, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down ADMA Biologics, Inc. and Xencor, Inc.'s Expenses